PBSV
Price
$0.58
Change
+$0.03 (+5.45%)
Updated
Nov 25 closing price
Capitalization
13.27M
62 days until earnings call
Intraday BUY SELL Signals
PMCUF
Price
$174.66
Change
-$5.34 (-2.97%)
Updated
Dec 2 closing price
Capitalization
17.95B
Intraday BUY SELL Signals
Interact to see
Advertisement

PBSV vs PMCUF

Header iconPBSV vs PMCUF Comparison
Open Charts PBSV vs PMCUFBanner chart's image
Pharma-Bio Serv
Price$0.58
Change+$0.03 (+5.45%)
Volume$3.08K
Capitalization13.27M
Pro Medicus
Price$174.66
Change-$5.34 (-2.97%)
Volume$215
Capitalization17.95B
PBSV vs PMCUF Comparison Chart in %
PBSV
Daily Signal:
Gain/Loss:
PMCUF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PBSV vs. PMCUF commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBSV is a Hold and PMCUF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (PBSV: $0.58 vs. PMCUF: $180.00)
Brand notoriety: PBSV and PMCUF are both not notable
Both companies represent the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: PBSV: 64% vs. PMCUF: 37%
Market capitalization -- PBSV: $13.27M vs. PMCUF: $17.95B
PBSV [@Services to the Health Industry] is valued at $13.27M. PMCUF’s [@Services to the Health Industry] market capitalization is $17.95B. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $39.52B to $0. The average market capitalization across the [@Services to the Health Industry] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PBSV’s FA Score shows that 1 FA rating(s) are green whilePMCUF’s FA Score has 2 green FA rating(s).

  • PBSV’s FA Score: 1 green, 4 red.
  • PMCUF’s FA Score: 2 green, 3 red.
According to our system of comparison, PMCUF is a better buy in the long-term than PBSV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PBSV’s TA Score shows that 3 TA indicator(s) are bullish while PMCUF’s TA Score has 4 bullish TA indicator(s).

  • PBSV’s TA Score: 3 bullish, 5 bearish.
  • PMCUF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PMCUF is a better buy in the short-term than PBSV.

Price Growth

PBSV (@Services to the Health Industry) experienced а 0.00% price change this week, while PMCUF (@Services to the Health Industry) price change was +12.23% for the same time period.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was -0.68%. For the same industry, the average monthly price growth was -6.38%, and the average quarterly price growth was +4.43%.

Reported Earning Dates

PBSV is expected to report earnings on Feb 04, 2026.

Industries' Descriptions

@Services to the Health Industry (-0.68% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PMCUF($17.9B) has a higher market cap than PBSV($13.3M). PMCUF has higher P/E ratio than PBSV: PMCUF (249.57) vs PBSV (20.23). PBSV YTD gains are higher at: 20.313 vs. PMCUF (15.927). PMCUF has higher annual earnings (EBITDA): 165M vs. PBSV (-442.11K). PMCUF has more cash in the bank: 209M vs. PBSV (10.7M). PBSV has less debt than PMCUF: PBSV (71.4K) vs PMCUF (2.26M). PMCUF has higher revenues than PBSV: PMCUF (213M) vs PBSV (9.19M).
PBSVPMCUFPBSV / PMCUF
Capitalization13.3M17.9B0%
EBITDA-442.11K165M-0%
Gain YTD20.31315.927128%
P/E Ratio20.23249.578%
Revenue9.19M213M4%
Total Cash10.7M209M5%
Total Debt71.4K2.26M3%
FUNDAMENTALS RATINGS
PBSV vs PMCUF: Fundamental Ratings
PBSV
PMCUF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
96
Overvalued
PROFIT vs RISK RATING
1..100
10029
SMR RATING
1..100
9119
PRICE GROWTH RATING
1..100
5164
P/E GROWTH RATING
1..100
1976
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PBSV's Valuation (63) in the null industry is somewhat better than the same rating for PMCUF (96). This means that PBSV’s stock grew somewhat faster than PMCUF’s over the last 12 months.

PMCUF's Profit vs Risk Rating (29) in the null industry is significantly better than the same rating for PBSV (100). This means that PMCUF’s stock grew significantly faster than PBSV’s over the last 12 months.

PMCUF's SMR Rating (19) in the null industry is significantly better than the same rating for PBSV (91). This means that PMCUF’s stock grew significantly faster than PBSV’s over the last 12 months.

PBSV's Price Growth Rating (51) in the null industry is in the same range as PMCUF (64). This means that PBSV’s stock grew similarly to PMCUF’s over the last 12 months.

PBSV's P/E Growth Rating (19) in the null industry is somewhat better than the same rating for PMCUF (76). This means that PBSV’s stock grew somewhat faster than PMCUF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PBSVPMCUF
RSI
ODDS (%)
N/A
Bullish Trend 6 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 6 days ago
63%
Momentum
ODDS (%)
Bullish Trend 6 days ago
72%
Bearish Trend 6 days ago
54%
MACD
ODDS (%)
Bullish Trend 6 days ago
73%
Bullish Trend 6 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
59%
Bearish Trend 6 days ago
53%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 6 days ago
46%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 28 days ago
78%
Bearish Trend 23 days ago
48%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
54%
Bullish Trend 6 days ago
66%
Aroon
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
PBSV
Daily Signal:
Gain/Loss:
PMCUF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HYPD3.890.19
+5.14%
Hyperion DeFi Inc
RAL48.73-0.05
-0.10%
Ralliant Corporation
BP36.37-0.14
-0.38%
BP plc
DHC4.76-0.06
-1.35%
Diversified Healthcare Trust
CCCC2.43-0.10
-4.13%
C4 Therapeutics

PBSV and

Correlation & Price change

A.I.dvisor tells us that PBSV and MFON have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PBSV and MFON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBSV
1D Price
Change %
PBSV100%
N/A
MFON - PBSV
25%
Poorly correlated
N/A
ZUKI - PBSV
24%
Poorly correlated
N/A
PONGF - PBSV
9%
Poorly correlated
N/A
PMCUF - PBSV
6%
Poorly correlated
N/A
PANHF - PBSV
4%
Poorly correlated
N/A
More

PMCUF and

Correlation & Price change

A.I.dvisor tells us that PMCUF and OCLCF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PMCUF and OCLCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMCUF
1D Price
Change %
PMCUF100%
N/A
OCLCF - PMCUF
32%
Poorly correlated
N/A
TMSNY - PMCUF
29%
Poorly correlated
N/A
FSLY - PMCUF
29%
Poorly correlated
-0.94%
NEXXY - PMCUF
22%
Poorly correlated
N/A
TMNSF - PMCUF
21%
Poorly correlated
N/A
More